Global Neuroprotection Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The Global Neuroprotection Market is expected to grow from USD 9,685.87 Million in 2018 to USD 17,865.87 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.13%.
The positioning of the Global Neuroprotection Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Neuroprotection Market including are Allergan plc, Dr. Reddy's Laboratories, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Astrocyte Pharmaceuticals Inc., Biogen Inc., Daiichi Sankyo Company, Limited, Novartis AG, Roche Holding AG, and Teva Pharmaceutical Industries Ltd..
On the basis of Product, the Global Neuroprotection Market is studied across Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists, Metal Ion Chelators, Neurotrophic Factors, Radical Trapping Agents, and Stimulants.
On the basis of Treatment, the Global Neuroprotection Market is studied across Alzheimer's disease, Amyotrophic lateral sclerosis, Brain injury, Huntington's disease, Multiple sclerosis, Neuropathies, Ocular degeneration, and Parkinson's disease.
On the basis of Application, the Global Neuroprotection Market is studied across Prevention and Treatment.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Neuroprotection Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Neuroprotection Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Neuroprotection Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Neuroprotection Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Neuroprotection Market
The report answers questions such as:
1. What is the market size of Neuroprotection market in the Global?
2. What are the factors that affect the growth in the Global Neuroprotection Market over the forecast period?
3. What is the competitive position in the Global Neuroprotection Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Neuroprotection Market?
5. What are the opportunities in the Global Neuroprotection Market?
6. What are the modes of entering the Global Neuroprotection Market?
The positioning of the Global Neuroprotection Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Neuroprotection Market including are Allergan plc, Dr. Reddy's Laboratories, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Astrocyte Pharmaceuticals Inc., Biogen Inc., Daiichi Sankyo Company, Limited, Novartis AG, Roche Holding AG, and Teva Pharmaceutical Industries Ltd..
On the basis of Product, the Global Neuroprotection Market is studied across Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists, Metal Ion Chelators, Neurotrophic Factors, Radical Trapping Agents, and Stimulants.
On the basis of Treatment, the Global Neuroprotection Market is studied across Alzheimer's disease, Amyotrophic lateral sclerosis, Brain injury, Huntington's disease, Multiple sclerosis, Neuropathies, Ocular degeneration, and Parkinson's disease.
On the basis of Application, the Global Neuroprotection Market is studied across Prevention and Treatment.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Neuroprotection Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Neuroprotection Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Neuroprotection Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Neuroprotection Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Neuroprotection Market
The report answers questions such as:
1. What is the market size of Neuroprotection market in the Global?
2. What are the factors that affect the growth in the Global Neuroprotection Market over the forecast period?
3. What is the competitive position in the Global Neuroprotection Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Neuroprotection Market?
5. What are the opportunities in the Global Neuroprotection Market?
6. What are the modes of entering the Global Neuroprotection Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Neuroprotection Market
3.2. Opportunities in the Neuroprotection Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing drug development in the pharmaceutical and biotechnology owing to increasing occurrences of traumatic brain injury
4.2.1.2. Growing incidences of CNS diseases coupled with increasing awareness
4.2.1.3. Increased demand for target-specific drug treatment for neurodegenerative diseases along with favorable government regulations
4.2.1.4. Increasing healthcare infrastructure and increasing economic stability in developing economies, such as Latin America and Middle East & Africa
4.2.2. Restraints
4.2.2.1. Limited awareness in developing economies
4.2.3. Opportunities
4.2.3.1. New product launch, investment in R&D, and increasing drug discovery & product launch
4.2.3.2. Increasing use of neuroprotection in cosmetics
4.2.3.3. Increasing use of herbal extract free-radical trapping agents such as cannabidiol, Vitamins E and C
4.2.4. Challenges
4.2.4.1. High cost associated with neuro treatments
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL NEUROPROTECTION MARKET, BY PRODUCT
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Apoptosis Inhibitors
5.4. Free Anti-Inflammatory Agents
5.5. Glutamate Antagonists
5.6. Metal Ion Chelators
5.7. Neurotrophic Factors
5.8. Radical Trapping Agents
5.9. Stimulants
6. GLOBAL NEUROPROTECTION MARKET, BY TREATMENT
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Alzheimer's disease
6.4. Amyotrophic lateral sclerosis
6.5. Brain injury
6.6. Huntington's disease
6.7. Multiple sclerosis
6.8. Neuropathies
6.9. Ocular degeneration
6.10. Parkinson's disease
7. GLOBAL NEUROPROTECTION MARKET, BY APPLICATION
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Prevention
7.4. Treatment
8. GLOBAL NEUROPROTECTION MARKET, BY GEOGRAPHY
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. 360iResearch FPNV Positioning Matrix for Global Neuroprotection Market
9.2. Market Vendor Ranking Analysis for Global Neuroprotection Market
9.3. Competitive News Feed Analysis for Global Neuroprotection Market
10. COMPANY USABILITY PROFILES
10.1. Allergan plc
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Dr. Reddy's Laboratories
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. Eli Lilly and Company
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Teva Pharmaceutical Industries Ltd.
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. AstraZeneca plc
10.6. Astrocyte Pharmaceuticals Inc.
10.7. Biogen Inc.
10.8. Daiichi Sankyo Company, Limited
10.9. Novartis AG
10.10. Roche Holding AG
10.11. Teva Pharmaceutical Industries Ltd.
11. APPENDIX
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Neuroprotection Market
3.2. Opportunities in the Neuroprotection Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing drug development in the pharmaceutical and biotechnology owing to increasing occurrences of traumatic brain injury
4.2.1.2. Growing incidences of CNS diseases coupled with increasing awareness
4.2.1.3. Increased demand for target-specific drug treatment for neurodegenerative diseases along with favorable government regulations
4.2.1.4. Increasing healthcare infrastructure and increasing economic stability in developing economies, such as Latin America and Middle East & Africa
4.2.2. Restraints
4.2.2.1. Limited awareness in developing economies
4.2.3. Opportunities
4.2.3.1. New product launch, investment in R&D, and increasing drug discovery & product launch
4.2.3.2. Increasing use of neuroprotection in cosmetics
4.2.3.3. Increasing use of herbal extract free-radical trapping agents such as cannabidiol, Vitamins E and C
4.2.4. Challenges
4.2.4.1. High cost associated with neuro treatments
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL NEUROPROTECTION MARKET, BY PRODUCT
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Apoptosis Inhibitors
5.4. Free Anti-Inflammatory Agents
5.5. Glutamate Antagonists
5.6. Metal Ion Chelators
5.7. Neurotrophic Factors
5.8. Radical Trapping Agents
5.9. Stimulants
6. GLOBAL NEUROPROTECTION MARKET, BY TREATMENT
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Alzheimer's disease
6.4. Amyotrophic lateral sclerosis
6.5. Brain injury
6.6. Huntington's disease
6.7. Multiple sclerosis
6.8. Neuropathies
6.9. Ocular degeneration
6.10. Parkinson's disease
7. GLOBAL NEUROPROTECTION MARKET, BY APPLICATION
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Prevention
7.4. Treatment
8. GLOBAL NEUROPROTECTION MARKET, BY GEOGRAPHY
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. 360iResearch FPNV Positioning Matrix for Global Neuroprotection Market
9.2. Market Vendor Ranking Analysis for Global Neuroprotection Market
9.3. Competitive News Feed Analysis for Global Neuroprotection Market
10. COMPANY USABILITY PROFILES
10.1. Allergan plc
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Dr. Reddy's Laboratories
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. Eli Lilly and Company
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Teva Pharmaceutical Industries Ltd.
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. AstraZeneca plc
10.6. Astrocyte Pharmaceuticals Inc.
10.7. Biogen Inc.
10.8. Daiichi Sankyo Company, Limited
10.9. Novartis AG
10.10. Roche Holding AG
10.11. Teva Pharmaceutical Industries Ltd.
11. APPENDIX
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
